Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

Clinical trial NCT07443774 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07443774
Sponsor: University Hospital, Grenoble
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

ER+ Breast Cancer Breast Cancer Early Breast Cancer Endocrine Therapy Abemaciclib Ribociclib

Start date: 2026-04-01
Primary completion: 2031-04-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.